Roles of catecholamine related polymorphisms in hypertension

doi:10.5494/wjh.v6.i1.41

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10083)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

737

WORD

353

HTML

4055

Figures (1-3)

279

Tables (1-1)

241

Sum=5665

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

603

Download

1438

Sum=2041

Publishing Process of This Article

Item

Count

Browse

1034

Download

1343

Sum=2377

Feb 23, 2016 (publication date) through Dec 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hypertension

ISSN

2220-3168

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hypertens. Feb 23, 2016; 6(1): 41-52
Published online Feb 23, 2016. doi: 10.5494/wjh.v6.i1.41

Full Size Figure Download Figure

Figure 2 Enzymatic degradation process of dopamine.

Citation: Orun O. Roles of catecholamine related polymorphisms in hypertension. World J Hypertens 2016; 6(1): 41-52
URL: https://www.wjgnet.com/2220-3168/full/v6/i1/41.htm
DOI: https://dx.doi.org/10.5494/wjh.v6.i1.41